Anti-MADD Antibody

The Antibodies.com polyclonal reagent targets the MADD protein (MAP-kinase activating death domain), an adaptor involved in TNF receptor signaling, ERK activation, and stress-induced apoptosis pathways. Raised in rabbit and supplied as an unconjugated 100 µl aliquot, the antibody can be paired with user-selected secondary reagents for western blot, immunohistochemistry, immunofluorescence, and ELISA workflows. Cross-reactivity has been validated against Human, Mouse, and Rat samples, supporting translational studies in cell-line and primary tissue models of neurodegeneration, metabolic dysfunction, and tumor biology. The polyclonal format offers broader epitope coverage than monoclonal alternatives, useful when monitoring MADD isoform expression or post-translational modification states across experimental conditions.